Rittenhouse Hematology Oncology — Philadelphia, Pennsylvania

Rittenhouse Hematology Oncology is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rittenhouse Hematology Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Advanced Solid Tumor.

Sponsors: DualityBio Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rittenhouse Hematology Oncology?

Rittenhouse Hematology Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rittenhouse Hematology Oncology conducted?

Rittenhouse Hematology Oncology has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Advanced Solid Tumor.

Is Rittenhouse Hematology Oncology accredited by Crixeo Health?

Rittenhouse Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rittenhouse Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.